Electro-Acupuncture for Obese Patients With Insulin Resistance
Electro-acupuncture for the Obese Patient With Insulin Resistance: a Randomized Sham-controlled Clinical Trial
Nanyang Technological University
60 participants
Oct 10, 2024
INTERVENTIONAL
Conditions
Summary
This clinical trial aims to evaluate the efficacy and safety of electro-acupuncture for obese patients with insulin resistance. 60 participants will be randomized and allocated to either the electro-acupuncture arm or the sham acupuncture arm.
Eligibility
Inclusion Criteria4
- Men and women aged between 21 and 65 years old
- BMI ≥ 25 kg/m2
- HOMA-IR ≥ 2.14, (HOMA-IR = fasting insulin (ųU/mL)* fasting glucose (mmol/L)/22.5)
- Not receiving any other weight control measures or any medical and/or drug history in the last 3 months
Exclusion Criteria10
- Diabetes mellitus
- Treating with drugs that may affect insulin sensitivity
- Changes 10% of usual body weight in the previous 6 months weight
- Endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc.
- Heart diseases, including arrhythmia, heart failure, and myocardial infarction, participants with pacemakers
- Allergy and immunology diseases
- Bleeding tendency
- Pregnant or lactating women
- Impaired hepatic or renal function
- Stroke or unable to exercise
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The acupuncture needles and related equipment will have already received approval for routine Traditional Chinese Medicine (TCM) clinical practice in Singapore.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06609200